Immucell ICCC
NASDAQ ICCC
$10.22 +0.42 (+4.29%)
At close: Nov 9, 2026 · 4:00 PM EST

Immucell (ICCC) Net Long-Term Debt Issued (Repaid) (2010 - 2026)

Updated

Immucell's Non-Current Debt was -$19,306 in FY2022, compared with $2,272 in FY2021.

Analysis

Immucell (ICCC) Net Long-Term Debt Issued (Repaid) (2010 - 2026) Analysis & Trends

  • Per Business Quant data, Non-Current Debt in earlier years was $2,272 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -1.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 9.98 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Immucell 94.09 Mn 70.73 Mn 2.44 Mn -402,537.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -402,537.00
Mar 31, 2026 -399,999.00
Dec 31, 2025 -394,602.00
Sep 30, 2025 1.20 Mn
Jun 30, 2025 -381,438.00
Mar 31, 2025 -380,106.00
Dec 31, 2024 -374,232.00
Sep 30, 2024 -368,250.00
Jun 30, 2024 -364,350.00
Mar 31, 2024 -361,506.00
Dec 31, 2023 -356,759.00
Sep 30, 2023 -325,737.00
Jun 30, 2023 -251,901.00
Mar 31, 2023 -251,376.00
Dec 31, 2022 -248,207.00
Sep 30, 2022 -223,102.00
Jun 30, 2022 -228,431.00
Mar 31, 2022 1.80 Mn
Dec 31, 2021 -194,905.00
Sep 30, 2021 -192,357.00
API Access

Immucell Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ICCC&period=max&api_key=YOUR_API_KEY